Development of analytical methods allowing to determine the tolerability, pharmacokinetics and pharmacodynamics of various treatments under development for retinopathy. The results will allow the sele...
Semathera Inc.
7 records totalling $1,239,481.00 CAD, from official Government of Canada open data.
Embed this chart
By department
| National Research Council Canada | $1,231,520 | 6 records |
| Global Affairs Canada | $7,961 | 1 record |
Records
A novel treatment that will offer a new alternative to poor responders of currrent therapies of diabetic macular edema.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The purpose of this CanExport Innovation grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countr...